These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes). Tamis-Holland JE; Lu J; Korytkowski M; Magee M; Rogers WJ; Lopes N; Mighton L; Jacobs AK; J Am Coll Cardiol; 2013 Apr; 61(17):1767-76. PubMed ID: 23500245 [TBL] [Abstract][Full Text] [Related]
3. Optimal medical management of peripheral arterial disease. Rice TW; Lumsden AB Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725 [TBL] [Abstract][Full Text] [Related]
4. API expert consensus document on management of ischemic heart disease. Association of Physicians of India J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697 [TBL] [Abstract][Full Text] [Related]
5. Preventing recurrent events long term after coronary artery bypass graft: suboptimal use of medications in a population study. Bradshaw PJ; Jamrozik K; Gilfillan I; Thompson PL Am Heart J; 2004 Jun; 147(6):1047-53. PubMed ID: 15199354 [TBL] [Abstract][Full Text] [Related]
6. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566 [TBL] [Abstract][Full Text] [Related]
7. Current strategies for the prevention of angina in patients with stable coronary artery disease. Bhatt AB; Stone PH Curr Opin Cardiol; 2006 Sep; 21(5):492-502. PubMed ID: 16900014 [TBL] [Abstract][Full Text] [Related]
8. Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery. Gurfinkel EP; Perez de la Hoz R; Brito VM; Duronto E; Dabbous OH; Gore JM; Anderson FA; Int J Cardiol; 2007 Jun; 119(1):65-72. PubMed ID: 17045681 [TBL] [Abstract][Full Text] [Related]
9. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study). Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D; Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158 [TBL] [Abstract][Full Text] [Related]
10. The editor's roundtable: role of percutaneous coronary intervention and drug-eluting stents in patients with stable coronary heart disease. Friedewald VE; Boden WE; Stone GW; Yancy CW; Roberts WC Am J Cardiol; 2011 Nov; 108(10):1417-25. PubMed ID: 22040718 [No Abstract] [Full Text] [Related]
11. Secondary prevention of coronary artery disease. Hall SL; Lorenc T Am Fam Physician; 2010 Feb; 81(3):289-96. PubMed ID: 20112887 [TBL] [Abstract][Full Text] [Related]
12. Management of stable angina. Jain A; Wadehra V; Timmis AD Postgrad Med J; 2003 Jun; 79(932):332-6. PubMed ID: 12840122 [TBL] [Abstract][Full Text] [Related]
14. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart. Anselmino M; Malmberg K; Ohrvik J; Rydén L; Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):216-23. PubMed ID: 18391651 [TBL] [Abstract][Full Text] [Related]
15. Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease. Dagenais GR; Lu J; Faxon DP; Kent K; Lago RM; Lezama C; Hueb W; Weiss M; Slater J; Frye RL; Circulation; 2011 Apr; 123(14):1492-500. PubMed ID: 21444887 [TBL] [Abstract][Full Text] [Related]
16. [Evidence-based optimal treatment strategy of patients with angina pectoris]. Jánosi A Orv Hetil; 2008 Feb; 149(7):293-8. PubMed ID: 18258559 [TBL] [Abstract][Full Text] [Related]
17. Under-use of secondary prevention medication in acute coronary syndrome patients treated with in-hospital coronary artery bypass graft surgery. Looi KL; Chow KL; Looi JL; Lee M; Halliday S; White H; Ellis C N Z Med J; 2011 Sep; 124(1343):18-27. PubMed ID: 21964009 [TBL] [Abstract][Full Text] [Related]
18. Comparison of secondary prevention of heart disease in Europe: lifestyle getting worse, therapy getting better in Ireland. Hall M; McGettigan M; O'Callaghan P; Graham I; Shelley E; Feely J Ir Med J; 2002 Oct; 95(9):272-4. PubMed ID: 12469998 [TBL] [Abstract][Full Text] [Related]
19. [Secondary prevention of coronary heart disease. How effective are modern therapy methods?]. Kolenda KD Dtsch Med Wochenschr; 2003 Sep; 128(36):1849-53. PubMed ID: 12964107 [No Abstract] [Full Text] [Related]
20. Coronary revascularization (surgical or percutaneous) decreases mortality after the first year in diabetic subjects but not in nondiabetic subjects with multivessel disease: an analysis from the Medicine, Angioplasty, or Surgery Study (MASS II). Soares PR; Hueb WA; Lemos PA; Lopes N; Martinez EE; Cesar LA; Oliveira SA; Ramires JA Circulation; 2006 Jul; 114(1 Suppl):I420-4. PubMed ID: 16820611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]